Ajanta Pharma Limited
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Ajanta Pharma Limited's balance sheet done over the years? Its assets were worth $46,383,900,000 last year, which is more than in the previous period. 23% of Ajanta Pharma Limited’s total assets is currently financed by debt. Its liabilities reached the amount of $10,710,300,000, which means an increase by 35% compared compared to last year.
Debt to Assets
| 2011 | 5221672000 | 2.93B | 56.18% |
|---|---|---|---|
| 2012 | 6488062000 | 3.50B | 54.06% |
| 2015 | 11463500000 | 3.05B | 26.63% |
| 2016 | 14814300000 | 3.09B | 20.88% |
| 2018 | 24485900000 | 4.07B | 16.63% |
| 2019 | 26961800000 | 4.50B | 16.73% |
| 2020 | 33186900000 | 7.19B | 21.69% |
| 2021 | 37787200000 | 7.83B | 20.72% |
| 2022 | 40555800000 | 7.91B | 19.51% |
| 2024 | 46383900000 | 10.71B | 23.09% |
AJANTPHARM.NS Balance Sheet (2011 – 2023)
| 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 1.29B | 2.06B | 1.77B | 2.02B | 951.6M | 906.4M | 549.6M | 1.36B | 114.73M | 147.60M |
Short term investments | 3.30B | 1.21B | 2.00B | 671.4M | 647.4M | 1.84B | 663.9M | 194.6M | 0 | 0 |
Net receivables | 12.46B | 11.45B | 7.59B | 8.31B | 5.50B | 4.59B | 3.72B | 2.58B | 0 | 0 |
Inventory | 8.28B | 7.91B | 7.66B | 4.95B | 4.35B | 3.50B | 2.04B | 1.59B | 1.67B | 1.13B |
Other current assets | 1.96B | 200K | 1.23B | 8.76B | 5.85B | 1.40B | 680.7M | 594M | 1.60B | 1.54B |
Total current assets | 27.30B | 22.64B | 20.27B | 16.41B | 11.81B | 12.23B | 7.63B | 6.33B | 3.39B | 2.82B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 17.20B | 16.47B | 16.29B | 15.82B | 14.33B | 11.06B | 6.85B | 4.53B | 2.34B | 2.31B |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 146.6M | 90.2M | 107.9M | 117.1M | 66.5M | 74.5M | 59.8M | 43.1M | 142.72M | 0 |
Long term investments | 227.4M | 294.2M | 39.5M | 159.3M | 130M | -1.77B | 42.8M | 205.8M | 0 | 0 |
Other non-current assets | 1.49B | 497.1M | 566.8M | 410.4M | 303.1M | 2.65B | 74.8M | 340.7M | 604.97M | 84.64M |
Total non-current assets | 19.07B | 17.91B | 17.51B | 16.76B | 15.14B | 12.24B | 7.17B | 5.12B | 3.09B | 2.39B |
Total assets | 46.38B | 40.55B | 37.78B | 33.18B | 26.96B | 24.48B | 14.81B | 11.46B | 6.48B | 5.22B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 393.2M | 2.49B | 2.32B | 1.81B | -353M | 37.2M | 42.2M | 1.01B | 0 | 0 |
Short term debt | 117.6M | 64.6M | 115.9M | 622.5M | 353M | 7.9M | 622.6M | 391.3M | 0 | 0 |
Total current liabilities | 8.95B | 6.47B | 6.48B | 6.06B | 3.77B | 3.46B | 2.71B | 2.49B | 2.50B | 917.85M |
| Non-current liabilities: | ||||||||||
Long term debt | 235.2M | 185.7M | 197.7M | 127.1M | 6.6M | 10.1M | 159.1M | 332.5M | 760.89M | 1.90B |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 109.20M |
Other non-current liabilities | 434.2M | 204.1M | 191.8M | 161.1M | 137.7M | 601.6M | 20.2M | 176.6M | 74.10M | 0 |
Total non-current liabilities | 1.75B | 1.43B | 1.34B | 1.13B | 733.3M | 611.7M | 379M | 556.7M | 1.00B | 2.01B |
Total liabilities | 10.71B | 7.91B | 7.83B | 7.19B | 4.50B | 4.07B | 3.09B | 3.05B | 3.50B | 2.93B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |